Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study

Saved in:
Bibliographic Details
Published in:Kidney360 2024-05, Vol.5 (5), p.732-742
Main Authors: Sprague, Stuart M, Weiner, Daniel E, Tietjen, David P, Pergola, Pablo E, Fishbane, Steven, Block, Geoffrey A, Silva, Arnold L, Fadem, Stephen Z, Lynn, Robert I, Fadda, George, Pagliaro, Lynae, Zhao, Suling, Edelstein, Susan, Spiegel, David M, Rosenbaum, David P
Format: Article
Language:English
Subjects:
Dialysis
Female
Humans
Hyperphosphatemia - etiology
Hyperphosphatemia - therapy
Isoquinolines - therapeutic use
Male
Middle Aged
Original Investigation
Renal Dialysis - adverse effects
Sulfonamides - therapeutic use
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2641-7650
2641-7650
DOI:10.34067/KID.0000000000000387